Molecular Diagnostics

Summary

Molecular diagnostics market is being driven by several growth factors that include the need for automated and easy-to-handle techniques, which combine optimized sample preparation, analysis, and data evaluation, and the growing availability of molecular diagnostic tests for monitoring the therapeutic efficacy of expensive drugs. Additionally, the requirement of swift diagnoses techniques that would diagnose disease condition and medical disorders quickly and offer a strong and consistent tool for quick therapy decisions represents the other key factor. In terms of technological push, genomics and proteomics are the major drivers of the molecular diagnostic market. Nanobiotechnology and biochips are of key interest to the molecular diagnostics market.

Demand for molecular diagnostics and gene detection products is determined by the volume of tests performed in clinical labs, which continues to be miniscule in comparison to large battery of conventional diagnostic lab tests. However, provoked by the rate at which molecular tests is growing, companies are investing heavily in molecular diagnostics and gene detection systems to realize the potential in the offing.

These and other market data and trends are presented in "Molecular Diagnostics: A World Market Review" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Contents

• 1.Methodology
  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Quantitative Techniques & Reporting Level
• 2.Industry Overview
  • Global Market Outlook
  • Molecular Diagnostics - The Fastest Growing Medical Diagnostic- Technology
  • New Applications Hold Promising Potential
  • Automated Systems - Prime Target
  • Infectious Disease Testing Drives The Diagnostics Market
  • The Future in Store
• 3.A Review of Medical Diagnostics Market
  • Clinical Diagnostics Industry - Trends and Tendencies
  • Diagnostic Tests - Classification
  • Nucleic Acid Diagnostics Market - An Overview
  • Molecular Diagnostics - Growth Drivers
  • Molecular Diagnostics - A Replacement and Enabling Technology
  • Molecular Diagnostics for Lymphoid Malignancies
• 4.Competitive Dynamics in The Molecular Diagnostics Market
  • Key Players and Their Technologies
  • The Top Tier
  • Mid-Sized and Small Companies
• 5.Market Trends & Issues
  • Market Consolidations on The Way to Integrate in Vivo and in Vitro Diagnostics
  • Global Molecular Diagnostics on High Growth Curve
  • Pharmaceutical Firms Carving Their Niche in Molecular Diagnostic Market
  • towards Tailoring The Right Treatment for The Right Disease
  • Disease-Specific Molecular Diagnostics to Deliver Improved Clinical Outcomes
  • Molecular Diagnostics and Intellectual Property
  • Business Opportunities in The Offing
  • Challenges Facing The Molecular Diagnostic Market
  • Medical Training and Practice Challenges
  • Shortcomings to Overcome
  • Limited Reimbursements by Third Party Payers - A Stumbling Block
  • Hurdles All The Way for Companies Eyeing Molecular Diagnostics
  • Product Marketing - Key to Commercial Success
  • Integration of Molecular Diagnostics into Therapeutics
  • Molecular Diagnostics - Moving from Centralization to Decentralization
  • Migrating to Decentralized Format
  • Going Ahead with Decentralization
• 6.Product Facts
  • Infectious Diseases Testing
  • Pharmacogenomics
  • Cancer Screening
• 7.Corporate Developments
  • Vermillion, Johns Hopkins Ink Agreements Todevelop Molecular Diagnostic-Tests
  • Beckman Coulter Inks Licensing Agreements with National University of Ireland
  • Roche Takes over Bioveris
  • Siemens Acquires Dade Behring
  • Diagnocure Acquires Catalyst Oncology
  • Burrill & Co Takes over Expression Diagnostics
  • Solis Acquires Bertrand
  • Paragondx Llc Purchases Gentris Diagnostics
  • Beckman Collaborates to Discover Cvd Symptoms
  • Exiqon to Take over Oncotech
  • Roche to Acquire Ventana
  • Qiagen Merges with Digene
  • Qiagen & Bio One Capital Collaborates
  • Agt & Mal Signs Mou
  • Qiagen Obtains Licenses to Real-Time Pcr
  • Cepheid Purchases Sangtec
  • Source Mdx Collaborates with Pfizer
  • Nanosphere Receives Fda Clearance Forsecond Molecular Diagnostic Test
  • Qiagen Acquires Egene
  • Quest Diagnostics Acquires Ameripath
  • Mayo and Ilmn Team up to Develop Molecular Diagnostics for Complex- Diseases
  • Cheo and Ilmn Team up to Develop Molecular Diagnostics for Newborn Screening
  • Siemens Medical Solutions USA Sets up Siemens Medical Solutions Diagnostics
  • Tmd Launches Test for K-Ras Mutations in Colorectal Cancer Patients
  • Combimatrix Releases Updated Version of Constitutional Genetic Array Test
  • Myriad Introduces Theraguide 5-Fu
  • Cmdx Unveils First HemescanPrognostic
  • Combimatrix Introduces HemescanMds
• 8.Major Players
  • Abbott Laboratories (US)
  • Abbott Molecular (US)
  • Applera Corporation (US)
  • Celera (US)
  • Biomrieux (France)
  • Cytocore Inc (US)
  • Ge Healthcare (US)
  • Gen-Probe Inc (US)
  • Genzyme Corporation (US)
  • Genzyme Genetics (US)
  • Miraibio, Inc. (US)
  • Nanogen (US)
  • Novartis Vaccines & Diagnostics, Inc. (US)
  • Qiagen N.V (The Netherlands)
  • Quest Diagnostics, Inc. (USA)
  • Roche Diagnostics (Switzerland)
  • Siemens Healthcare Diagnostics (US)
  • Tecan Group Ltd. (Switzerland)
• 9.Global Market Analytics
• 10.The United States
  • A Precursor to The Molecular Diagnostics Market in The US
  • Molecular Diagnostics Heavily Tied to Proteomics and Genomics
  • Burgeoning Potential for Genetic Testing
  • Regulatory Environment
  • Regulations out for Molecular Diagnostic Testing of Hpv
  • Limited Reimbursements - A Major Hindrance
• 11.Canada
• 12.Japan
• 13.Europe
  • A.France
  • B.Germany
  • C.Italy
  • D.The United Kingdom
  • E.Rest of Europe
• 14.Asia-Pacific
  • Indian Diagnostic Market
• 15.Rest of World
  • Table 1: Percentage Breakdown of Worldwide in Vitro Diagnostics (Ivd) Market -
  • Table 2: Percentage Breakdown of Leading Players in The Worldwide in Vitro Diagnostics (Ivd) Market -
  • Table 3: Percentage Breakdown of Leading Players in The Worldwide Molecular Diagnostics Market -
  • Table 4: Percentage Breakdown of Leading Players in The Worldwide Genetic Testing Market -
  • Table 5: Percentage Breakdown of Worldwide Cancer Diagnostic Testing Market -
  • Table 6: Global Molecular Diagnostics Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 7: Percentage Breakdown of Global Molecular Diagnostics Market by Region for The Years 2008 &
  • Table 8: Global Molecular Diagnostics (Infectious Disease Testing) Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 9: Percentage Breakdown of Global Molecular Diagnostics (Infectious Disease Testing) Market by Region for The Years 2008 &
  • Table 10: Global Molecular Diagnostics (Pharmacogenomics) Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 11: Percentage Breakdown of Global Molecular Diagnostics (Pharmacogenomics) Market by Region for The Years 2008 &
  • Table 12: Global Molecular Diagnostics (Cancer Screening) Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 13: Percentage Breakdown of Global Molecular Diagnostics (Cancer Screening) Market by Region for The Years 2008 &
  • Table 14: Molecular Diagnostics Market by Product Segment in The US: 2007-2015 (Sales in US$ Million)
  • Table 15: Percentage Breakdown of Molecular Diagnostics Market by Product Segment in The US for The Years 2008 &
  • Table 16: Molecular Diagnostics Market by Product Segment in Canada: 2007-2015 (Sales in US$ Million)
  • Table 17: Percentage Breakdown of Molecular Diagnostics Market by Product Segment in Canada for The Years 2008 &
  • Table 18: Molecular Diagnostics Market by Product Segment in Japan: 2007-2015 (Sales in US$ Million)
  • Table 19: Percentage Breakdown of Molecular Diagnostics Market by Product Segment in Japan for The Years 2008 &
  • Table 20: Market Shares of Leading Players in The European Molecular Diagnostics Market -
  • Table 21: Molecular Diagnostics Market by Region in Europe: 2007-2015 (Sales in US$ Million)
  • Table 22: Percentage Breakdown of Molecular Diagnostics Market by Region in Europe for The Years 2008 &
  • Table 23: Molecular Diagnostics Market by Product Segment in Europe: 2007-2015 (Sales in US$ Million)
  • Table 24: Percentage Breakdown of Molecular Diagnostics Market by Product Segment in Europe for The Years 2008 &
  • Table 25: Molecular Diagnostics Market by Product Segment in France: 2007-2015 (Sales in US$ Million)
  • Table 26: Percentage Breakdown of Molecular Diagnostics Market by Product Segment in France for The Years 2008 &
  • Table 27: Molecular Diagnostics Market by Product Segment in Germany: 2007-2015 (Sales in US$ Million)
  • Table 28: Percentage Breakdown of Molecular Diagnostics Market by Product Segment in Germany for The Years 2008 &
  • Table 29: Molecular Diagnostics Market by Product Segment in Italy: 2007-2015 (Sales in US$ Million)
  • Table 30: Percentage Breakdown of Molecular Diagnostics Market by Product Segment in Italy for The Years 2008 &
  • Table 31: Molecular Diagnostics Market by Product Segment in The UK: 2007-2015 (Sales in US$ Million)
  • Table 32: Percentage Breakdown of Molecular Diagnostics Market by Product Segment in The UK for The Years 2008 &
  • Table 33: Molecular Diagnostics Market by Product Segment in Rest of Europe: 2007-2015 (Sales in US$ Million)
  • Table 34: Percentage Breakdown of Molecular Diagnostics Market by Product Segment in Rest of Europe for The Years 2008 &
  • Table 35: Molecular Diagnostics Market by Product Segment in Asia-Pacific: 2007-2015 (Sales in US$ Million)
  • Table 36: Percentage Breakdown of Molecular Diagnostics Market by Product Segment in Asia-Pacific for The Years 2008 &
  • Table 37: Molecular Diagnostics Market by Product Segment in Rest of World: 2007-2015 (Sales in US$ Million)
  • Table 38: Percentage Breakdown of Molecular Diagnostics Market by Product Segment in Rest of World for The Years 2008 &
• Companies Profiled